Unknown NA INTERVENTIONAL 2-arm NCT00974285

Clinical Trials on the Effect of Immunity 1 (Fuzheng 1) on Immune Reconstitution of HIV Patients

Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trials on the Effect of Immunity 1 (Fuzheng 1) on Immune Reconstitution of HIV Patients

Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Conditions Acquired Immune Deficiency Syndrome Virus HIV Infections

Interventions Fuzheng 1 Placebo

Updated 5 times since 2017 Last updated: Oct 28, 2009 Started: Sep 30, 2009 Primary completion: Jun 30, 2010 Completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00974285, this NA trial focuses on Acquired Immune Deficiency Syndrome Virus and HIV Infections and remains ongoing. Sponsored by Guang'anmen Hospital of China Academy of Chinese Medical Sciences, it has been updated 5 times since 2009, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Sep 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Data source: Guang'anmen Hospital of China Academy of Chinese Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China